Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc.

Sector: Pharmaceutical Preparations Region: CA, United States

: | Nasdaq: OREX

Similar to: NPS Pharmaceuticals, Inc., AstraZeneca Plc, Trius Therapeutics, Inc.

Orexigen Therapeutics, Inc. is a biopharmaceutical company that is engaged in the development of pharmaceutical product candidates for the treatment of obesity. Its two lead products are Contrave, which is a weight loss medication for the management of obesity and Empatic, which is an immediate release formulation, approved for the adjunctive treatment of partial seizures, a form of epilepsy. Orexigen Therapeutics was founded by Eckard Weber in September 2002 and is headquartered in La Jolla, CA.

News & Analysis

You may also be interested in: